{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0003-3120",
      "generic_name": "nivolumab and hyaluronidase-nvhy",
      "labeler_name": "E.R. Squibb & Sons, L.L.C.",
      "brand_name": "OPDIVO QVANTIG",
      "active_ingredients": [
        {
          "name": "NIVOLUMAB",
          "strength": "120 mg/mL"
        },
        {
          "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
          "strength": "2000 U/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0003-3120-01",
          "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0003-3120-01)  / 2.5 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20251124",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "E.R. Squibb & Sons, L.L.C."
        ],
        "rxcui": [
          "2700798",
          "2700805",
          "2728491",
          "2728492"
        ],
        "spl_set_id": [
          "7f8c38fa-42f4-4387-9e8c-7a1c66855d8b"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191260",
          "N0000191259",
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_epc": [
          "Programmed Death Receptor-1 Blocking Antibody [EPC]",
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_moa": [
          "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
        ],
        "pharm_class_cs": [
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "31YO63LBSN",
          "743QUY4VD8"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "1ce25608-1b8f-4d49-9ffd-6c8c61bf4f1a",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20241227",
      "product_id": "0003-3120_1ce25608-1b8f-4d49-9ffd-6c8c61bf4f1a",
      "application_number": "BLA761381",
      "brand_name_base": "OPDIVO QVANTIG",
      "pharm_class": [
        "Endoglycosidase [EPC]",
        "Glycoside Hydrolases [CS]",
        "Programmed Death Receptor-1 Blocking Antibody [EPC]",
        "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
      ]
    }
  ]
}